{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:55:37Z","timestamp":1770738937322,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12026-020-09124-w","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T17:02:38Z","timestamp":1586192558000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis"],"prefix":"10.1007","volume":"68","author":[{"given":"Georgios","family":"Efthymiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Liaskos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Simopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouela","family":"Marou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Patrikiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Daoussis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"issue":"6","key":"9124_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/BOR.0000000000000113","volume":"26","author":"RT Domsic","year":"2014","unstructured":"Domsic RT. Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement. Curr Opin Rheumatol. 2014;26(6):646\u201352. https:\/\/doi.org\/10.1097\/BOR.0000000000000113.","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"9124_CR2","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","volume":"71","author":"FM Meier","year":"2012","unstructured":"Meier FM, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR scleroderma trials and research group database. Ann Rheum Dis. 2012;71(8):1355\u201360. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200742.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"9124_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ncprheum0346","volume":"2","author":"LI Sakkas","year":"2006","unstructured":"Sakkas LI, Chikanza IC, Platsoucas CD. Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat Clin Pract Rheumatol. 2006;2(12):679\u201385. https:\/\/doi.org\/10.1038\/ncprheum0346.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"5","key":"9124_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","volume":"76","author":"M Manetti","year":"2017","unstructured":"Manetti M, Romano E, Rosa I, Guiducci S, Bellando-Randone S, De Paulis A, et al. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Ann Rheum Dis. 2017;76(5):924\u201334. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210229.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"9124_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/art.39437","volume":"68","author":"A Mavropoulos","year":"2016","unstructured":"Mavropoulos A, Simopoulou T, Varna A, Liaskos C, Katsiari CG, Bogdanos DP, et al. Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheum. 2016;68(2):494\u2013504. https:\/\/doi.org\/10.1002\/art.39437.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"9124_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/art.39421","volume":"68","author":"FA Mendoza","year":"2016","unstructured":"Mendoza FA, Piera-Velazquez S, Farber JL, Feghali-Bostwick C, Jimenez SA. Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease. Arthritis Rheum. 2016;68(1):210\u20137. https:\/\/doi.org\/10.1002\/art.39421.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"9124_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","volume":"15","author":"LI Sakkas","year":"2016","unstructured":"Sakkas LI, Bogdanos DP. Systemic sclerosis: new evidence re-enforces the role of B cells. Autoimmun Rev. 2016;15(2):155\u201361. https:\/\/doi.org\/10.1016\/j.autrev.2015.10.005.","journal-title":"Autoimmun Rev"},{"key":"9124_CR8","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3389\/fimmu.2018.02452","volume":"9","author":"A van Caam","year":"2018","unstructured":"van Caam A, Vonk M, van den Hoogen F, van Lent P, van der Kraan P. Unraveling SSc pathophysiology; The Myofibroblast. Front Immunol. 2018;9:2452. https:\/\/doi.org\/10.3389\/fimmu.2018.02452.","journal-title":"Front Immunol"},{"issue":"2\u20133","key":"9124_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12026-013-8399-6","volume":"56","author":"DP Bogdanos","year":"2013","unstructured":"Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Sakkas L, et al. Tracing environmental markers of autoimmunity: introducing the infectome. Immunol Res. 2013;56(2\u20133):220\u201340. https:\/\/doi.org\/10.1007\/s12026-013-8399-6.","journal-title":"Immunol Res"},{"issue":"4\u20135","key":"9124_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/0961203314559088","volume":"24","author":"DP Bogdanos","year":"2015","unstructured":"Bogdanos DP, Smyk DS, Rigopoulou EI, Sakkas LI, Shoenfeld Y. Infectomics and autoinfectomics: a tool to study infectious-induced autoimmunity. Lupus. 2015;24(4\u20135):364\u201373. https:\/\/doi.org\/10.1177\/0961203314559088.","journal-title":"Lupus."},{"issue":"5","key":"9124_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00281-015-0507-3","volume":"37","author":"I Marie","year":"2015","unstructured":"Marie I, Gehanno JF. Environmental risk factors of systemic sclerosis. Semin Immunopathol. 2015;37(5):463\u201373. https:\/\/doi.org\/10.1007\/s00281-015-0507-3.","journal-title":"Semin Immunopathol"},{"key":"9124_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of systemic sclerosis. Front Immunol. 2015;6:272. https:\/\/doi.org\/10.3389\/fimmu.2015.00272.","journal-title":"Front Immunol"},{"key":"9124_CR13","doi-asserted-by":"publisher","unstructured":"Efthymiou G, Dardiotis E, Liaskos C, Marou E, Scheper T, Meyer W, et al. A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis. Clin Immunol. 2019. https:\/\/doi.org\/10.1016\/j.clim.2019.07.012.","DOI":"10.1016\/j.clim.2019.07.012"},{"issue":"4","key":"9124_CR14","first-page":"31","volume":"35 Suppl 106","author":"E Marou","year":"2017","unstructured":"Marou E, Liaskos C, Efthymiou G, Dardiotis E, Daponte A, Scheper T, et al. Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis. Clin Exp Rheumatol. 2017;35 Suppl 106(4):31\u20134.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"9124_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10067-017-3553-5","volume":"36","author":"E Marou","year":"2017","unstructured":"Marou E, Liaskos C, Simopoulou T, Efthymiou G, Dardiotis E, Katsiari C, et al. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis. Clin Rheumatol. 2017;36(4):863\u20139. https:\/\/doi.org\/10.1007\/s10067-017-3553-5.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"9124_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jbspin.2011.01.006","volume":"78","author":"J Kountouras","year":"2011","unstructured":"Kountouras J, Zavos C, Gavalas E, Deretzi G, Katsinelos P, Boura P, et al. Helicobacter pylori may be a common denominator associated with systemic and multiple sclerosis. Joint, Bone, Spine. 2011;78(2):222\u20133; author reply 3. https:\/\/doi.org\/10.1016\/j.jbspin.2011.01.006.","journal-title":"Joint, Bone, Spine"},{"issue":"4","key":"9124_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jbspin.2010.10.005","volume":"78","author":"M Radic","year":"2011","unstructured":"Radic M, Kaliterna DM, Radic J. Helicobacter pylori infection and systemic sclerosis-is there a link? Joint, Bone, Spine. 2011;78(4):337\u201340. https:\/\/doi.org\/10.1016\/j.jbspin.2010.10.005.","journal-title":"Joint, Bone, Spine"},{"issue":"11","key":"9124_CR18","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s00296-012-2585-z","volume":"33","author":"M Radic","year":"2013","unstructured":"Radic M, Kaliterna DM, Bonacin D, Vergles JM, Radic J, Fabijanic D, et al. Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? Rheumatol Int. 2013;33(11):2943\u20138. https:\/\/doi.org\/10.1007\/s00296-012-2585-z.","journal-title":"Rheumatol Int"},{"issue":"4","key":"9124_CR19","first-page":"168","volume":"36 Suppl 113","author":"WC Yong","year":"2018","unstructured":"Yong WC, Upala S, Sanguankeo A. Helicobacter pylori infection in systemic sclerosis: a systematic review and meta-analysis of observational studies. Clin Exp Rheumatol. 2018;36 Suppl 113(4):168\u201374.","journal-title":"Clin Exp Rheumatol"},{"issue":"18","key":"9124_CR20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2169\/internalmedicine.47.1128","volume":"47","author":"K Yamaguchi","year":"2008","unstructured":"Yamaguchi K, Iwakiri R, Hara M, Kikkawa A, Fujise T, Ootani H, et al. Reflux esophagitis and Helicobacter pylori infection in patients with scleroderma. Intern Med. 2008;47(18):1555\u20139. https:\/\/doi.org\/10.2169\/internalmedicine.47.1128.","journal-title":"Intern Med"},{"issue":"9","key":"9124_CR21","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/rheumatology\/keq137","volume":"49","author":"M Radic","year":"2010","unstructured":"Radic M, Martinovic Kaliterna D, Bonacin D, Morovic Vergles J, Radic J. Correlation between Helicobacter pylori infection and systemic sclerosis activity. Rheumatology. 2010;49(9):1784\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/keq137.","journal-title":"Rheumatology."},{"issue":"2","key":"9124_CR22","first-page":"81","volume":"14","author":"G Farina","year":"2001","unstructured":"Farina G, Rosato E, Francia C, Proietti M, Donato G, Ammendolea C, et al. High incidence of Helicobacter pylori infection in patients with systemic sclerosis: association with Sicca syndrome. Int J Immunopathol Pharmacol. 2001;14(2):81\u20135.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"4","key":"9124_CR23","first-page":"650","volume":"25","author":"N Yazawa","year":"1998","unstructured":"Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, et al. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol. 1998;25(4):650\u20133.","journal-title":"J Rheumatol"},{"issue":"4","key":"9124_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1046\/j.1523-5378.2002.00092.x","volume":"7","author":"L Kalabay","year":"2002","unstructured":"Kalabay L, Fekete B, Czirjak L, Horvath L, Daha MR, Veres A, et al. Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter. 2002;7(4):250\u20136.","journal-title":"Helicobacter."},{"issue":"6","key":"9124_CR25","first-page":"1568","volume":"27","author":"S Danese","year":"2000","unstructured":"Danese S, Zoli A, Cremonini F, Gasbarrini A. High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol. 2000;27(6):1568\u20139.","journal-title":"J Rheumatol"},{"issue":"6","key":"9124_CR26","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3906\/sag-1404-150","volume":"45","author":"H Bilgin","year":"2015","unstructured":"Bilgin H, Kocabas H, Kesli R. The prevalence of infectious agents in patients with systemic sclerosis. Turkish J Med Sci. 2015;45(6):1192\u20137.","journal-title":"Turkish J Med Sci"},{"issue":"7","key":"9124_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1348-0421.1996.tb01100.x","volume":"40","author":"Y Showji","year":"1996","unstructured":"Showji Y, Nozawa R, Sato K, Suzuki H. Seroprevalence of Helicobacter pylori infection in patients with connective tissue diseases. Microbiol Immunol. 1996;40(7):499\u2013503.","journal-title":"Microbiol Immunol"},{"issue":"2","key":"9124_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1523-5378.1997.tb00062.x","volume":"2","author":"LB Lachman","year":"1997","unstructured":"Lachman LB, Ozpolat B, Rao XM, Graham DY, Osato M. Development of a murine model of Helicobacter pylori infection. Helicobacter. 1997;2(2):78\u201381.","journal-title":"Helicobacter."},{"issue":"5204","key":"9124_CR29","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.7886456","volume":"267","author":"M Marchetti","year":"1995","unstructured":"Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 1995;267(5204):1655\u20138. https:\/\/doi.org\/10.1126\/science.7886456.","journal-title":"Science."},{"issue":"4","key":"9124_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1139\/m90-041","volume":"36","author":"MT Cantorna","year":"1990","unstructured":"Cantorna MT, Balish E. Inability of human clinical strains of Helicobacter pylori to colonize the alimentary tract of germfree rodents. Can J Microbiol. 1990;36(4):237\u201341. https:\/\/doi.org\/10.1139\/m90-041.","journal-title":"Can J Microbiol"},{"issue":"52","key":"9124_CR31","first-page":"2827","volume":"141","author":"Z Csiki","year":"2000","unstructured":"Csiki Z, Gal I, Sebesi J, Szegedi G. Raynaud syndrome and eradication of Helicobacter pylori. Orv Hetil. 2000;141(52):2827\u20139.","journal-title":"Orv Hetil"},{"issue":"8","key":"9124_CR32","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1023\/a:1018842527111","volume":"43","author":"A Gasbarrini","year":"1998","unstructured":"Gasbarrini A, Massari I, Serricchio M, Tondi P, De Luca A, Franceschi F, et al. Helicobacter pylori eradication ameliorates primary Raynaud\u2019s phenomenon. Dig Dis Sci. 1998;43(8):1641\u20135. https:\/\/doi.org\/10.1023\/a:1018842527111.","journal-title":"Dig Dis Sci"},{"issue":"12","key":"9124_CR33","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1080\/003655200453575","volume":"35","author":"V Savarino","year":"2000","unstructured":"Savarino V, Sulli A, Zentilin P, Raffaella Mele M, Cutolo M. No evidence of an association between Helicobacter pylori infection and Raynaud phenomenon. Scand J Gastroenterol. 2000;35(12):1251\u20134.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"9124_CR34","first-page":"1820","volume":"27","author":"A Sulli","year":"2000","unstructured":"Sulli A, Seriolo B, Savarino V, Cutolo M. Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud\u2019s phenomenon in patients with systemic sclerosis. J Rheumatol. 2000;27(7):1820\u20131.","journal-title":"J Rheumatol"},{"issue":"10","key":"9124_CR35","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.revmed.2006.07.003","volume":"27","author":"F Herve","year":"2006","unstructured":"Herve F, Cailleux N, Benhamou Y, Ducrotte P, Lemeland JF, Denis P, et al. Helicobacter pylori prevalence in Raynaud\u2019s disease. La Revue de Medecine Interne. 2006;27(10):736\u201341. https:\/\/doi.org\/10.1016\/j.revmed.2006.07.003.","journal-title":"La Revue de Medecine Interne"},{"issue":"2","key":"9124_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3325\/cmj.2009.50.124","volume":"50","author":"T Filipec Kanizaj","year":"2009","unstructured":"Filipec Kanizaj T, Katicic M, Presecki V, Gasparov S, Colic Cvrlje V, Kolaric B, et al. Serum antibodies positivity to 12 Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases\u2014cross-sectional study. Croatian Med J. 2009;50(2):124\u201332. https:\/\/doi.org\/10.3325\/cmj.2009.50.124.","journal-title":"Croatian Med J"},{"issue":"1","key":"9124_CR37","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1038\/s41598-017-07801-9","volume":"7","author":"G Efthymiou","year":"2017","unstructured":"Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Rigopoulou EI, et al. Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis. Sci Rep. 2017;7(1):7929. https:\/\/doi.org\/10.1038\/s41598-017-07801-9.","journal-title":"Sci Rep"},{"issue":"11","key":"9124_CR38","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1212\/01.wnl.0000145705.82690.04","volume":"63","author":"S Chiba","year":"2004","unstructured":"Chiba S, Sugiyama T, Yonekura K, Tanaka S, Matsumoto H, Fujii N, et al. An antibody to VacA of Helicobacter pylori in the CSF of patients with Miller-Fisher syndrome. Neurology. 2004;63(11):2184\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000145705.82690.04.","journal-title":"Neurology."},{"issue":"1","key":"9124_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/jnnp.73.1.76","volume":"73","author":"S Chiba","year":"2002","unstructured":"Chiba S, Sugiyama T, Yonekura K, Tanaka S, Matsumoto H, Fujii N, et al. An antibody to VacA of Helicobacter pylori in cerebrospinal fluid from patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2002;73(1):76\u20138. https:\/\/doi.org\/10.1136\/jnnp.73.1.76.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"9124_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1523-5378.2007.00477.x","volume":"12","author":"M Kodama","year":"2007","unstructured":"Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, et al. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter. 2007;12(1):36\u201342. https:\/\/doi.org\/10.1111\/j.1523-5378.2007.00477.x.","journal-title":"Helicobacter."},{"key":"9124_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2016.06.009","volume":"298","author":"G Efthymiou","year":"2016","unstructured":"Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Scheper T, et al. Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)relevance to disease pathogenesis. J Neuroimmunol. 2016;298:19\u201323. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.06.009.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"9124_CR42","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1742-1241.2005.00778.x","volume":"60","author":"M Sezikli","year":"2006","unstructured":"Sezikli M, Guliter S, Apan TZ, Aksoy A, Keles H, Ozkurt ZN. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases. Int J Clin Pract. 2006;60(10):1239\u201343. https:\/\/doi.org\/10.1111\/j.1742-1241.2005.00778.x.","journal-title":"Int J Clin Pract"},{"issue":"2","key":"9124_CR43","first-page":"153","volume":"36","author":"D Us","year":"2002","unstructured":"Us D, Engin D, Hascelik G. Evaluation of western blot methods for serologic diagnosis of Helicobacter pylori infections. Mikrobiyoloji Bulteni. 2002;36(2):153\u201360.","journal-title":"Mikrobiyoloji Bulteni"},{"key":"9124_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fmicb.2015.00052","volume":"6","author":"KW Cook","year":"2015","unstructured":"Cook KW, Crooks J, Hussain K, O'Brien K, Braitch M, Kareem H, et al. Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis. Front Microbiol. 2015;6:52. https:\/\/doi.org\/10.3389\/fmicb.2015.00052.","journal-title":"Front Microbiol"},{"issue":"6","key":"9124_CR45","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/ibd.21489","volume":"17","author":"PD Higgins","year":"2011","unstructured":"Higgins PD, Johnson LA, Luther J, Zhang M, Sauder KL, Blanco LP, et al. Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine. Inflamm Bowel Dis. 2011;17(6):1398\u2013408. https:\/\/doi.org\/10.1002\/ibd.21489.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"9124_CR46","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1172\/JCI45041","volume":"121","author":"IC Arnold","year":"2011","unstructured":"Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest. 2011;121(8):3088\u201393. https:\/\/doi.org\/10.1172\/JCI45041.","journal-title":"J Clin Invest"},{"issue":"4","key":"9124_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095367","volume":"9","author":"S Yoshimura","year":"2014","unstructured":"Yoshimura S, Isobe N, Matsushita T, Masaki K, Sato S, Kawano Y, et al. Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. PLoS One. 2014;9(4):e95367. https:\/\/doi.org\/10.1371\/journal.pone.0095367.","journal-title":"PLoS One"},{"issue":"2","key":"9124_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4081\/ni.2013.e10","volume":"5","author":"N Mohebi","year":"2013","unstructured":"Mohebi N, Mamarabadi M, Moghaddasi M. Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients. Neurol Int. 2013;5(2):31\u20133. https:\/\/doi.org\/10.4081\/ni.2013.e10.","journal-title":"Neurol Int"},{"issue":"1\u20132","key":"9124_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jneuroim.2006.12.010","volume":"184","author":"W Li","year":"2007","unstructured":"Li W, Minohara M, Su JJ, Matsuoka T, Osoegawa M, Ishizu T, et al. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol. 2007;184(1\u20132):227\u201331. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.12.010.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"9124_CR50","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/ana.410400405","volume":"40","author":"J Kira","year":"1996","unstructured":"Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, Kawano Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol. 1996;40(4):569\u201374. https:\/\/doi.org\/10.1002\/ana.410400405.","journal-title":"Ann Neurol"},{"issue":"9","key":"9124_CR51","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1172\/JCI38605","volume":"119","author":"JC Atherton","year":"2009","unstructured":"Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest. 2009;119(9):2475\u201387. https:\/\/doi.org\/10.1172\/JCI38605.","journal-title":"J Clin Invest"},{"issue":"3","key":"9124_CR52","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbrc.2015.03.096","volume":"460","author":"S Nakashima","year":"2015","unstructured":"Nakashima S, Kakugawa T, Yura H, Tomonaga M, Harada T, Hara A, et al. Identification of Helicobacter pylori VacA in human lung and its effects on lung cells. Biochem Biophys Res Commun. 2015;460(3):721\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.096.","journal-title":"Biochem Biophys Res Commun"},{"key":"9124_CR53","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.micpath.2018.07.038","volume":"123","author":"AC Arismendi Sosa","year":"2018","unstructured":"Arismendi Sosa AC, Salinas Ibanez AG, Perez Chaca MV, Penissi AB, Gomez NN, Vega AE. Study of Helicobacter pylori infection on lung using an animal model. Microb Pathog. 2018;123:410\u20138. https:\/\/doi.org\/10.1016\/j.micpath.2018.07.038.","journal-title":"Microb Pathog"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-020-09124-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09124-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:12:38Z","timestamp":1617667958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-020-09124-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["9124"],"URL":"https:\/\/doi.org\/10.1007\/s12026-020-09124-w","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"6 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study conformed to the principles in the Declaration of Helsinki. A written informed consent was obtained from all patients and controls. This study was carried out after approval of the Ethical Committee of the University General Hospital of Larissa (Protocol Number: 2406\/18-06-2015).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Thomas Scheper and Wolfgang Meyer are employees of Euroimmun AG. All other authors do not have conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}